Do you want to read an article? Please log in or register.
The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Related content
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
Lancet Gastroenterol Hepatol.
Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B
doi: 10.1016/S2468-1253(20)30119-9.
Inflammatory Bowel Disease
Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic
J Crohns Colitis.
Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV
doi: 10.1093/ecco-jcc/jjaa119.
Inflammatory Bowel Disease
Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey
Inflamm Bowel Dis.
Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD
doi: 10.1093/ibd/izaa142.
Celiac DiseaseIrritable Bowel Syndrome (IBS) and Chronic ConstipationInflammatory Bowel Disease
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease
Dig Dis.
Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, Lucci L, Accarino G, Caporaso N, Castiglione F
doi: 10.1159/000489487.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease
J Formos Med Assoc.
Lei WY, Chang WC, Wen SH, Wong MW, Hung JS, Yi CH, Liu TT, Hsu CS, Orr WC, Vaezi MF, Pace F, Hsieh TC, Chen CL
doi: 10.1016/j.jfma.2018.12.00
Inflammatory Bowel Disease
Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis
United European Gastroenterol J
Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S
doi: 10.1177/2050640620972602
COMMENTED
Inflammatory Bowel Disease
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD
doi: 10.1053/j.gastro.2020.05.032.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults
Gastroenterology.
Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, Surawicz CM, Chey WD
doi: 10.1053/j.gastro.2019.06.014.